Search research articles
Contact Us
Filters
Showing results (51-60 of 107) with videos related to
Page
of 11
Sort By:
Journal of Leukocyte Biology
|
February 24, 2001
Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis
K Hattar, U Sibelius, A Bickenbach, et al.
The Journal of Rheumatology
|
August 26, 1998
Elevated procalcitonin levels in active Wegener's granulomatosis
F Moosig, E Csernok, E Reinhold-Keller, et al.
Immunitat Und Infektion
|
February 1, 1991
[Distribution pattern of proteinase 3 in Wegener's granulomatosis and other vasculitic diseases]
M G Braun, E Csernok, H K Müller-Hermelink, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Treatment of Wegener's granulomatosis with intravenous immunoglobulin
C Richter, A Schnabel, E Csernok, et al.
Annals of the Rheumatic Diseases
|
April 22, 2005
Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
J U Holle, B Hellmich, M Backes, et al.
The American Journal of Pathology
|
October 1, 1991
Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues
M G Braun, E Csernok, W L Gross, et al.
Arthritis and Rheumatism
|
May 1, 1995
Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance
A Schnabel, E Csernok, D A Isenberg, et al.
Arthritis and Rheumatism
|
September 1, 1992
Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity
W H Schmitt, C Heesen, E Csernok, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Treatment modalities and ANCA in Takayasu's arteritis
M Schwarz-Eywill, A Breitbart, E Csernok, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Autoantibodies directed against lysozyme: a new target antigen for anti-neutrophil cytoplasmic antibodies (ANCA)
W H Schmitt, E Csernok, B K Flesch, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 107) with videos related to
Sort By:
Page
of 11
Journal of Leukocyte Biology
|
February 24, 2001
Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis
K Hattar, U Sibelius, A Bickenbach, et al.
The Journal of Rheumatology
|
August 26, 1998
Elevated procalcitonin levels in active Wegener's granulomatosis
F Moosig, E Csernok, E Reinhold-Keller, et al.
Immunitat Und Infektion
|
February 1, 1991
[Distribution pattern of proteinase 3 in Wegener's granulomatosis and other vasculitic diseases]
M G Braun, E Csernok, H K Müller-Hermelink, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Treatment of Wegener's granulomatosis with intravenous immunoglobulin
C Richter, A Schnabel, E Csernok, et al.
Annals of the Rheumatic Diseases
|
April 22, 2005
Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
J U Holle, B Hellmich, M Backes, et al.
The American Journal of Pathology
|
October 1, 1991
Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues
M G Braun, E Csernok, W L Gross, et al.
Arthritis and Rheumatism
|
May 1, 1995
Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance
A Schnabel, E Csernok, D A Isenberg, et al.
Arthritis and Rheumatism
|
September 1, 1992
Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity
W H Schmitt, C Heesen, E Csernok, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Treatment modalities and ANCA in Takayasu's arteritis
M Schwarz-Eywill, A Breitbart, E Csernok, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Autoantibodies directed against lysozyme: a new target antigen for anti-neutrophil cytoplasmic antibodies (ANCA)
W H Schmitt, E Csernok, B K Flesch, et al.
Page
of 11